This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Practice Guideline

. 2008 Jan;34(ACS-1):1-33.

Statement on the recommended use of pentavalent human-bovine reassortant rotavirus vaccine. An Advisory Committee Statement (ACS)

[Article in English, French]

National Advisory Committee on Immunization (NACI)

PMID: 18217293

Free article

Practice Guideline

Statement on the recommended use of pentavalent human-bovine reassortant rotavirus vaccine. An Advisory Committee Statement (ACS)

[Article in English, French]

National Advisory Committee on Immunization (NACI). Can Commun Dis Rep. 2008 Jan.

Free article

. 2008 Jan;34(ACS-1):1-33.

Author

National Advisory Committee on Immunization (NACI)

PMID: 18217293

No abstract available

PubMed Disclaimer

Similar articles

Prevention of rotavirus disease: guidelines for use of rotavirus vaccine.
American Academy of Pediatrics Committee on Infectious Diseases. American Academy of Pediatrics Committee on Infectious Diseases. Pediatrics. 2007 Jan;119(1):171-82. doi: 10.1542/peds.2006-3134. Pediatrics. 2007. PMID: 17200286 Clinical Trial.
The new pentavalent rotavirus vaccine composed of bovine (strain WC3) -human rotavirus reassortants.
Clark HF, Offit PA, Plotkin SA, Heaton PM. Clark HF, et al. Pediatr Infect Dis J. 2006 Jul;25(7):577-83. doi: 10.1097/01.inf.0000220283.58039.b6. Pediatr Infect Dis J. 2006. PMID: 16804425 Review.
Effects of the potency and composition of the multivalent human-bovine (WC3) reassortant rotavirus vaccine on efficacy, safety and immunogenicity in healthy infants.
Vesikari T, Clark HF, Offit PA, Dallas MJ, DiStefano DJ, Goveia MG, Ward RL, Schödel F, Karvonen A, Drummond JE, DiNubile MJ, Heaton PM. Vesikari T, et al. Vaccine. 2006 May 29;24(22):4821-9. doi: 10.1016/j.vaccine.2006.03.025. Epub 2006 Mar 31. Vaccine. 2006. PMID: 16621194 Clinical Trial.
Safety and efficacy of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine in healthy premature infants.
Goveia MG, Rodriguez ZM, Dallas MJ, Itzler RF, Boslego JW, Heaton PM, DiNubile MJ; REST Study Team. Goveia MG, et al. Pediatr Infect Dis J. 2007 Dec;26(12):1099-104. doi: 10.1097/INF.0b013e31814521cb. Pediatr Infect Dis J. 2007. PMID: 18043445 Clinical Trial.
RotaTeq: a three-dose oral pentavalent reassortant rotavirus vaccine.
Chandran A, Santosham M. Chandran A, et al. Expert Rev Vaccines. 2008 Dec;7(10):1475-80. doi: 10.1586/14760584.7.10.1475. Expert Rev Vaccines. 2008. PMID: 19053204 Review.

See all similar articles

Cited by

Importance of ICD-10 coding directive change for acute gastroenteritis (unspecified) for rotavirus vaccine impact studies: illustration from a population-based cohort study from Ontario, Canada.
Wilson SE, Deeks SL, Rosella LC. Wilson SE, et al. BMC Res Notes. 2015 Sep 15;8:439. doi: 10.1186/s13104-015-1412-5. BMC Res Notes. 2015. PMID: 26374397 Free PMC article.
The impact of publicly funded rotavirus immunization programs on Canadian children.
Muchaal PK, Hurst M, Desai S. Muchaal PK, et al. Can Commun Dis Rep. 2021 Mar 4;47(2):97-104. doi: 10.14745/ccdr.v47i02a02. eCollection 2021 Mar 4. Can Commun Dis Rep. 2021. PMID: 33746618 Free PMC article.
Population-Level Impact of Ontario's Infant Rotavirus Immunization Program: Evidence of Direct and Indirect Effects.
Wilson SE, Rosella LC, Wang J, Le Saux N, Crowcroft NS, Harris T, Bolotin S, Deeks SL. Wilson SE, et al. PLoS One. 2016 May 11;11(5):e0154340. doi: 10.1371/journal.pone.0154340. eCollection 2016. PLoS One. 2016. PMID: 27168335 Free PMC article.
A universal infant rotavirus vaccine program in two delivery models: Effectiveness and adverse events following immunization.
Sanford C, Langley JM, Halperin SA, Zelman M, Mvrvp. Sanford C, et al. Hum Vaccin Immunother. 2015;11(4):870-4. doi: 10.1080/21645515.2015.1012028. Hum Vaccin Immunother. 2015. PMID: 25746110 Free PMC article.
Updated Statement on the use of Rotavirus Vaccines: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)^†.
[No authors listed] [No authors listed] Can Commun Dis Rep. 2010 Jul 16;36(ACS-4):1-37. doi: 10.14745/ccdr.v36i00a04. eCollection 2010 Jul 16. Can Commun Dis Rep. 2010. PMID: 31701956 Free PMC article. No abstract available.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Canada Communicable Disease Report